Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. (AVTX) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
avtx · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, Avalo Therapeutics, Inc. (AVTX) has a market cap — also referred to as its net worth or valuation — of $148,077,168, making it one of the top most valuable companies globally. Market Cap = $13.11 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Avalo Therapeutics, Inc. (AVTX) has a market cap — also referred to as its net worth or valuation — of $148,077,168 as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Avalo Therapeutics, Inc. reached its all-time high market cap of $196.6B on Jun 18, 2021. Comparing the Avalo Therapeutics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Avalo Therapeutics, Inc. net worth vs peers and ask how Avalo Therapeutics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
AVTX market cap · 6 questionsAvalo Therapeutics, Inc.'s net worth — measured as market capitalization — is $148,077,168 as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$13.11 (price) × shares outstanding.